Urokinase Plasminogen Activator Receptor-positive Solid Tumor
1 clinical trials · Condition
◉ Watch Urokinase Plasminogen Activator Receptor-positive Solid Tumor
| Record | Firm | Date |
|---|---|---|
| MNPR-101-PCTA-177Lu Expanded Access Program (EAP) for Patients With Solid Tumor Cancer (NCT06980519) | Monopar Therapeutics |
Track Urokinase Plasminogen Activator Receptor-positive Solid Tumor automatically
Every clearance here is in the API, with alerts when new ones post.